The case for & against
Bull & Bear analysis
Bullish
Aflac Incorporated (NYSE: AFL) is a leading provider of supplemental insurance in the United States and Japan, specializing in products that cover out-of-pocket healthcare expenses, particularly in cancer treatment and chronic illness. The company leverages its strong brand reputation and extensive distribution network to target consumers and businesses in these significant insurance markets, indicating its position as a dominant player within the supplemental insurance sector.
Bull says
- ↑Japan segment sales rose 25.5% YoY driven by new cancer product
- ↑Q1 2026 capital deployment of $1.3B in buybacks and dividends
- ↑MiRiTO cancer insurance lifts persistency to 93% in Japan
- ↑Adjusted ROE of 12.8% delivers a solid spread over capital costs
- ↑Rising healthcare expenses and rate sensitivity support premium growth
- ↑Strong factor profile: high earnings yield, robust profitability, low volatility
Bear says
- ↓Japanese earned premiums stagnating, risking lapsation outpacing new sales
- ↓Negative growth indicators and downward earnings revisions pressure outlook
- ↓Benefit ratio under pressure, potential for margin compression if claims normalize
- ↓Low liquidity and elevated leverage increase vulnerability in downturns
- ↓Regulatory constraints and limited institutional interest hinder top-line gains
- ↓Factor headwinds from weak growth and revision signals challenge stability
Investment themes with AFL
High Dividend Yield↑ +0.32%
Companies paying above-average dividends
AVGO · JPM · XOM
Buybacks↑ +0.48%
Companies repurchasing their own shares
C · JCI · WFC
Quality↑ +0.54%
Companies with strong fundamentals and stability
NVDA · AAPL · MSFT
L&H Insurance↑ +0.32%
PGR · TRV · ALL
Earnings Call · Q1 2026 · Mgmt. Guidance
Updated 05-01-2026neutral
Transcript signals
Bull points
- Aflac Incorporated reported net earnings per diluted share of $1.98 and adjusted earnings per diluted share of $1.75. These results reflect our focused execution of our strategy, thus creating long-term value for our shareholders.
- I'm excited about the value and innovation that they have produced and will continue to bring to the organization moving forward. With this in mind, I'm pleased with Athlete Japan's sales increase of a 25.5 percent increase for the first quarter.
- Aflac US has continued its prudent approach to expense management and maintaining a strong pre-tax margin, as Max will expand upon shortly.
Bear points
- leverage down to 21.2%. That is partially a function of the yen dollar exchange rate. As you may recall, we hold about two-thirds of our debt denominated in yen and one-third in US dollars.
- that Particular business, we've got some investments we're doing right now to try to get growth out of that business. But what you're seeing right now, it's slightly down to flat.
- Aflac Japan's underlying earned premiums, which excludes the impact of reinsurance, paid-up policies, and deferred profit liability, declined 1.3 percent.
Read full transcript analysis ›